Search research articles
Contact Us
Filters
Showing results (1-10 of 95) with videos related to
Page
of 10
Sort By:
Current Pharmaceutical Design
|
May 29, 2012
Tobacco, inflammation, and respiratory tract cancer
Javier Milara, Julio Cortijo
Journal of Clinical Medicine
|
September 14, 2019
Mucins as a New Frontier in Pulmonary Fibrosis
Beatriz Ballester, Javier Milara, Julio Cortijo
International Journal of Molecular Sciences
|
February 2, 2019
Idiopathic Pulmonary Fibrosis and Lung Cancer: Mechanisms and Molecular Targets
Beatriz Ballester, Javier Milara, Julio Cortijo
Oncotarget
|
April 29, 2020
Pirfenidone anti-fibrotic effects are partially mediated by the inhibition of MUC1 bioactivation
Beatriz Ballester, Javier Milara, Julio Cortijo
European Respiratory Review : an Official Journal of the European Respiratory Society
|
February 4, 2021
The role of mucin 1 in respiratory diseases
Beatriz Ballester, Javier Milara, Julio Cortijo
Thorax
|
July 12, 2013
Authors' response to: epithelial mesenchymal transition (EMT) in small airways of COPD patient
Javier Milara, Teresa Peiró, Adela Serrano, et al.
International Journal of Molecular Sciences
|
July 2, 2021
MUC16 Is Overexpressed in Idiopathic Pulmonary Fibrosis and Induces Fibrotic Responses Mediated by Transforming Growth Factor-β1 Canonical Pathway
Beatriz Ballester, Javier Milara, Paula Montero, et al.
Cells
|
December 24, 2021
Senescence Alterations in Pulmonary Hypertension
Inés Roger, Javier Milara, Nada Belhadj, et al.
International Journal of Molecular Sciences
|
July 2, 2021
Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms
Paula Montero, Javier Milara, Inés Roger, et al.
Thorax
|
January 10, 2013
Epithelial to mesenchymal transition is increased in patients with COPD and induced by cigarette smoke
Javier Milara, Teresa Peiró, Adela Serrano, et al.
Page
of 10
Search research articles
Search
Showing results (1-10 of 95) with videos related to
Sort By:
Page
of 10
Current Pharmaceutical Design
|
May 29, 2012
Tobacco, inflammation, and respiratory tract cancer
Javier Milara, Julio Cortijo
Journal of Clinical Medicine
|
September 14, 2019
Mucins as a New Frontier in Pulmonary Fibrosis
Beatriz Ballester, Javier Milara, Julio Cortijo
International Journal of Molecular Sciences
|
February 2, 2019
Idiopathic Pulmonary Fibrosis and Lung Cancer: Mechanisms and Molecular Targets
Beatriz Ballester, Javier Milara, Julio Cortijo
Oncotarget
|
April 29, 2020
Pirfenidone anti-fibrotic effects are partially mediated by the inhibition of MUC1 bioactivation
Beatriz Ballester, Javier Milara, Julio Cortijo
European Respiratory Review : an Official Journal of the European Respiratory Society
|
February 4, 2021
The role of mucin 1 in respiratory diseases
Beatriz Ballester, Javier Milara, Julio Cortijo
Thorax
|
July 12, 2013
Authors' response to: epithelial mesenchymal transition (EMT) in small airways of COPD patient
Javier Milara, Teresa Peiró, Adela Serrano, et al.
International Journal of Molecular Sciences
|
July 2, 2021
MUC16 Is Overexpressed in Idiopathic Pulmonary Fibrosis and Induces Fibrotic Responses Mediated by Transforming Growth Factor-β1 Canonical Pathway
Beatriz Ballester, Javier Milara, Paula Montero, et al.
Cells
|
December 24, 2021
Senescence Alterations in Pulmonary Hypertension
Inés Roger, Javier Milara, Nada Belhadj, et al.
International Journal of Molecular Sciences
|
July 2, 2021
Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms
Paula Montero, Javier Milara, Inés Roger, et al.
Thorax
|
January 10, 2013
Epithelial to mesenchymal transition is increased in patients with COPD and induced by cigarette smoke
Javier Milara, Teresa Peiró, Adela Serrano, et al.
Page
of 10